Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

Early hair loss links to metabolic issues in young Indian men.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Power-enhancing drugs can cause mood swings, aggression, anxiety, and physical side effects, questioning their overall benefits.

Some Middle Eastern plants may help treat diabetes and could be alternatives to current drugs, but more research is needed.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Medications for PCOS don't seem to raise heart disease risk.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

MC4R gene variants not linked to female hair loss.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.